Finding 1092644 (2024-001)

Significant Deficiency Repeat Finding
Requirement
C
Questioned Costs
-
Year
2024
Accepted
2024-12-20

AI Summary

  • Core Issue: Parallax Advanced Research did not document payment terms properly, leading to vendor payments exceeding 30 days from reimbursement requests.
  • Impacted Requirements: Compliance with FAR 52.216-7(b)(1) regarding timely payments for cost-reimbursement contracts.
  • Recommended Follow-Up: Review and update payment procedures to ensure compliance and mitigate risks associated with cash management.

Finding Text

Federal Program: Research and Development Cluster ALN: 12.615, 12.U01, and 12.RD. Compliance Requirement: Cash Management. Awarding Agency: U.S. Department of Defense and National Aeronautics and Space Administration. Criteria or Specific Requirement: For cost-reimbursement contracts under the Federal Acquisition Regulations (FAR), 52.216-7(b)(1), with relation to supplies and services purchased for use on the contract, "ordinary course of business" would be in accordance with the terms and conditions of a subcontract or invoice, and ordinarily within 30 days of the request to the federal government. Condition: The Organization, specifically the entity Parallax Advanced Research ("Parallax"), did not have adequate documentation of extended payment terms in the ordinary course of business, and exceeded the typical 30 days. Cause: Parallax has been extending terms and conditions of payments of vendors beyond 30 days from the date of reimbursement request, as necessary for overall operations and its cash management needs. Additionally, Parallax has also experienced timing challenges pertaining to cash collections. Effect: Subset of vendors were paid later tan 30 days from the date of the request for reimbursement from the government. Questioned costs: None. Context: It was noted that the Organization requested reimbursement from the federal agency for 13 expenditures; however, the subsequent payment to the vendor for those expenditures was not within 30 days of the requested reimbursement. There may have been terms and conditions agreed to with the vendor, that exceed the 30 days of the request to the federal government for reimbursement, but we did not pursue that additional documentation. We did observe that payment was made within 30 days of receipt of the cash from the federal agency for six of the 13 expenditures. Of the seven expenditures that were paid more than 30 days from the reimbursement date, only one related to a reimbursement date after January 2024, which is when Parallax increased its line of credit. Recommendation: The Organization should review its procedures and update as necessary. Views of responsible officials: The Organization will consider the observation and the risks associated to determine action plan to address the finding. See corrective action plan.

Categories

Cash Management Procurement, Suspension & Debarment

Other Findings in this Audit

  • 516196 2024-001
    Significant Deficiency Repeat
  • 516197 2024-001
    Significant Deficiency Repeat
  • 516198 2024-001
    Significant Deficiency Repeat
  • 516199 2024-001
    Significant Deficiency Repeat
  • 516200 2024-001
    Significant Deficiency Repeat
  • 516201 2024-001
    Significant Deficiency Repeat
  • 516202 2024-001
    Significant Deficiency Repeat
  • 516203 2024-001
    Significant Deficiency Repeat
  • 516204 2024-001
    Significant Deficiency Repeat
  • 516205 2024-001
    Significant Deficiency Repeat
  • 516206 2024-001
    Significant Deficiency Repeat
  • 516207 2024-001
    Significant Deficiency Repeat
  • 516208 2024-001
    Significant Deficiency Repeat
  • 516209 2024-001
    Significant Deficiency Repeat
  • 516210 2024-001
    Significant Deficiency Repeat
  • 516211 2024-001
    Significant Deficiency Repeat
  • 1092638 2024-001
    Significant Deficiency Repeat
  • 1092639 2024-001
    Significant Deficiency Repeat
  • 1092640 2024-001
    Significant Deficiency Repeat
  • 1092641 2024-001
    Significant Deficiency Repeat
  • 1092642 2024-001
    Significant Deficiency Repeat
  • 1092643 2024-001
    Significant Deficiency Repeat
  • 1092645 2024-001
    Significant Deficiency Repeat
  • 1092646 2024-001
    Significant Deficiency Repeat
  • 1092647 2024-001
    Significant Deficiency Repeat
  • 1092648 2024-001
    Significant Deficiency Repeat
  • 1092649 2024-001
    Significant Deficiency Repeat
  • 1092650 2024-001
    Significant Deficiency Repeat
  • 1092651 2024-001
    Significant Deficiency Repeat
  • 1092652 2024-001
    Significant Deficiency Repeat
  • 1092653 2024-001
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
12.RD 11268 A III Idiq $13.17M
12.RD 11236 Matrix $9.99M
12.615 11186 Apex $8.08M
12.RD 11205 F0002-F0004- Option 1 $5.39M
12.800 P-100460 $5.18M
12.RD P-100324 $3.66M
12.RD 11245 Stat $3.19M
12.RD 11255 in the Moment $2.56M
12.U01 11261 Onramp Hub: Ohio $1.61M
12.RD 11244 Scepter $1.55M
12.RD P-202470 $1.45M
12.RD 11221 Astra-Ist $1.15M
43.008 P-402090 $806,756
43.009 P-140100 $523,692
43.RD P-520107 $402,011
12.RD 11248 Geocog $379,970
43.008 P-402080 $325,480
43.RD P-520110 $314,839
11.024 Build to Scale $290,704
12.RD P-202370 $284,626
43.RD P-520049 $251,514
12.RD 11196 Darpa M2t $237,556
43.RD P-520156 $225,707
43.RD P-520062 $224,434
12.RD 11208 F0005 - To4 $160,021
43.RD P-520048 $152,122
59.058 Federal and State Technology Partnership Program $145,727
43.RD P-100500 $97,351
12.600 Community Investment $95,382
11.112 Market Development Cooperator Program $93,089
12.RD 11076 Hmt $79,730
43.001 P-402085 $66,543
43.001 P-370047 $66,375
43.002 P-420113 $57,093
43.001 P-370046 $52,380
12.RD 11207 Ist Meams $51,645
43.001 P-370044 $46,243
12.RD P-100612 $41,623
12.RD 11210 Admire $18,485
12.RD P-100455 $10,276
12.RD P-100981 $4,451
12.RD 11231 Talons $3,252
43.RD P-370050 $1,978
12.RD P-100457 $1,547
43.012 P-370045 $164
12.RD P-400331 $114
12.RD P-202373 $90
12.RD P-100458 $32
43.RD P-390100 $24
43.RD P-370053 $8